Armstrong Henry H Associates Inc Johnson & Johnson Transaction History

Armstrong Henry H Associates Inc

$998 Million
Q2 2024

A detailed history of Armstrong Henry H Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Armstrong Henry H Associates Inc holds 366,550 shares of JNJ stock, worth $54.9 Million. This represents 5.37% of its overall portfolio holdings.

Number of Shares

366,550

Previous 375,024 2.26%

Holding current value

$54.9 Million

Previous $54.8 Million 2.26%

% of portfolio

5.37%

Previous 0.44%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 02, 2024	SELL	$144.38 - $157.78 $1.22 Million - $1.34 Million	-8,474 Reduced 2.26%	366,550 $53.6 Million
Q2 2024 Jul 02, 2024	SELL	$144.38 - $157.78 $110,450 - $120,701	-765 Reduced 0.2%	375,024 $54.8 Million
Q1 2024 Apr 11, 2024	SELL	$155.22 - $162.74 $700,663 - $734,608	-4,514 Reduced 1.19%	375,789 $59.4 Million
Q4 2023 Jan 10, 2024	SELL	$145.6 - $158.88 $1.45 Million - $1.58 Million	-9,950 Reduced 2.55%	380,303 $59.6 Million
Q3 2023 Oct 16, 2023	SELL	$155.75 - $174.48 $471,143 - $527,802	-3,025 Reduced 0.77%	390,253 $60.8 Million

Q2 2023 Jul 10, 2023	SELL	$154.35 - $166.11 $1.11 Million - $1.2 Million	-7,208 Reduced 1.8%	393,278 $65.1 Million
Q1 2023 Apr 12, 2023	SELL	$151.05 - $180.26 $2 Million - $2.39 Million	-13,237 Reduced 3.2%	400,486 $62.1 Million
Q4 2022 Jul 10, 2023	BUY	$160.2 - $179.79 $2.12 Million - $2.38 Million	13,237 Added 3.31%	413,723 $73.1 Million
Q4 2022 Jan 09, 2023	SELL	$160.2 - $179.79 $819,423 - $919,625	-5,115 Reduced 1.22%	413,723 $73.1 Million
Q3 2022 Oct 12, 2022	BUY	$161.33 - $179.52 $382,029 - $425,103	2,368 Added 0.57%	418,838 $68.4 Million
Q2 2022 Jul 13, 2022	BUY	$168.19 - $186.01 $518,866 - $573,840	3,085 Added 0.75%	416,470 $73.9 Million
Q1 2022 Apr 27, 2022	SELL	$158.14 - $179.59 $881,314 - $1 Million	-5,573 Reduced 1.33%	413,385 $73.3 Million
Q4 2021 Jan 20, 2022	SELL	$155.93 - $173.01 $742,070 - $823,354	-4,759 Reduced 1.12%	418,958 $71.7 Million
Q3 2021 Oct 26, 2021	SELL	$161.5 - $179.47 $192,831 - $214,287	-1,194 Reduced 0.28%	423,717 $68.4 Million
Q2 2021 Jul 20, 2021	BUY	$159.48 - $171.07 $96,963 - $104,010	608 Added 0.14%	424,911 $70 Million
Q1 2021 Apr 20, 2021	SELL	$153.07 - $170.48 $187,357 - $208,667	-1,224 Reduced 0.29%	424,303 $69.7 Million
Q4 2020 Feb 01, 2021	SELL	$137.11 - $157.38 $605,340 - $694,832	-4,415 Reduced 1.03%	425,527 $67 Million
Q3 2020 Oct 26, 2020	SELL	$140.38 - $153.83 $467,886 - $512,715	-3,333 Reduced 0.77%	429,942 $64 Million
Q2 2020 Jul 22, 2020	SELL	$128.81 - $155.51 $132,545 - $160,019	-1,029 Reduced 0.24%	433,275 $60.9 Million
Q1 2020 May 05, 2020	BUY	$111.14 - $153.99 $443,559 - $614,574	3,991 Added 0.93%	434,304 $60 Million
Q4 2019 Jan 29, 2020	SELL	$127.5 - $146.44 $226,185 - $259,784	-1,774 Reduced 0.41%	430,313 $62.8 Million
Q3 2019 Oct 16, 2019	SELL	$126.95 - $142.14 $302,141 - $338,293	-2,380 Reduced 0.55%	432,087 $55.9 Million
Q2 2019 Jul 19, 2019	SELL	$131.15 - $144.24 $6.49 Million - $7.14 Million	-49,514 Reduced 10.23%	434,467 $60.5 Million
Q1 2019 Apr 16, 2019	SELL	$125.72 - $139.79 $1.04 Million - $1.15 Million	-8,244 Reduced 1.67%	483,981 $67.7 Million
Q4 2018 Jan 28, 2019	SELL	$122.84 - $147.84 $570,837 - $687,012	-4,647 Reduced 0.94%	492,225 $63.5 Million
Q3 2018 Oct 19, 2018	SELL	$121.58 - $142.88 $825,528 - $970,155	-6,790 Reduced 1.35%	496,872 $68.7 Million
Q2 2018 Jul 25, 2018	SELL	$119.4 - $131.76 $57,312 - $63,244	-480 Reduced 0.1%	503,662 $61.1 Million
Q1 2018 Apr 30, 2018	BUY	$125.1 - $148.14 $344,025 - $407,384	2,750 Added 0.55%	504,142 $65.8 Million
Q4 2017 Jan 23, 2018	BUY	$131.22 - $143.62 $270,969 - $296,575	2,065 Added 0.41%	501,392 $70.1 Million
Q3 2017 Oct 24, 2017	BUY	$129.47 - $135.38 $64.6 Million - $67.6 Million	499,327	499,327 $64.9 Million

Others Institutions Holding JNJ

# of Institutions

4,153

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $392B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Henry H Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Henry H Associates Inc with notifications on news.

Account

Armstrong Henry H Associates Inc Johnson & Johnson Transaction History